PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 70 | 2 |

Tytuł artykułu

Age-dependent lower or higher levels of hair mercury in autistic children than in healthy controls

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
An association between autism and early life exposure to mercury is a hotly debated issue. In this study, 91 autistic Polish children, male and female, 3-4 and 7-9 years old, were compared to 75 age- and sex-matched healthy children with respect to: demographic, perinatal, clinical and developmental measures, parental age, birth order, morphometric measures, vaccination history, and hair mercury content. In demographic and perinatal measures there were no consistent differences between the autistic and control groups. Autistic children had a significantly greater prevalence of adverse reactions after vaccinations and abnormal development than controls. Between 45 and 80% of autistic children experienced developmental regress. Autistic children significantly differed from healthy peers in the concentrations of mercury in hair: younger autistics had lower levels, while older – higher levels than their respective controls. The results suggest that autistic children differ from healthy children in metabolism of mercury, which seems to change with age.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

70

Numer

2

Opis fizyczny

p.196-208,fig.,ref.

Twórcy

  • Marie Curie Chair, Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warsaw, Poland
  • Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
autor
  • Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
  • Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
  • Department of Pharmacology and Physiology of the Nervous System, Institute of Psychiatry and Neurology, Warsaw, Poland

Bibliografia

  • Adams JB, Romdalvik J, Ramanujam VM, Legator MS (2007) Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A 70: 1046-1051.
  • Adams JB, Romdalvik J, Levine K E, Hu LW (2008) Mercury in first -cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90: 739 -753.
  • Alberti A, Pirrone P, Elia M, Waring RH, Romano C (1999) Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry 46: 420 -424.
  • Altarac M, Saroha E (2007) Lifetime prevalence of learning disability among US children. Pediatrics 119: S77-S83.
  • Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368: 210 -215. Ballatori N, Clarkson TW (1982) Developmental changes in the biliary excretion of methylmercury and glutathione. Science 216: 61-63.
  • Ballatori N, Clarkson TW (1985) Biliary secretion of gluta­thione and of glutathione -metal complexes. Fundam Appl Toxicol 5: 816-831.
  • Bernard S, Enayati A, Redwood L, Roger H, Binstock T (2001) Autism: a novel form of mercury poisoning. Med. Hypotheses 56: 462-471.
  • Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR (2003) A Case -Control Study of Mercury Burden in Children with Autistic Spectrum Disorders. J Amer Physicians and Surgeons 8: 76-79.
  • Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T (2005) Comparison of blood and brain mercury levels in infant monkeys exposed to methylmer- cury or vaccines containing thimerosal. Environ Health Perspect 113: 1015-1021.
  • Clarkson TW (1993) Mercury: major issues in environmen­tal health. Environ Health Perspect 100: 31-38.
  • Conners CK (1969) A teacher rating scale for use in drug studies with children. Am J Psychiatry 126: 884-888.
  • Desoto MC, Hitlan RT ( 2007) Blood levels of mercury are related to diagnosis of autism: a reanalysis of an impor­tant data set. J Child Neurol 22: 1308-1311.
  • Doherty RA, Gates AH, Landry T (1977) Methylmercury excretion: developmental changes in mouse and man. Pediatr Res 11: 416.
  • Drasch G, Schupp I, Höfl H, Reinke R, Roider G (1994) Mercury burden of human fetal and infant tissues. Eur J Pediatr 153: 607-610.
  • Fido A, Al-Saad S (2005) Toxic trace elements in the hair of children with autism. Autism 9: 290-298.
  • Gallagher C, Goodman M (2008) Hepatitis B triple series vaccine and developmental disability in US children aged 1- 9 years. Toxicol Environ Chem 90: 997-1008.
  • Gallagher C, Goodman M (2009) Hepatitis B vaccination of male neonates and autism. Annals Epidemiol: 19: 659­659.
  • Geier MR, Geier DA (2003) Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communica­tion. Exp Biol Med 228: 660-664.
  • Geier DA, Geier MR (2006) A meta-analysis epidemio- logical assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 27: 401-413.
  • Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR (2009a). Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 280: 101-108.
  • Geier DA, Kern JK, Geier MR (2009b) A prospective study of prenatal mercury exposure from maternal dental amal­gams and autism severity. Acta Neurobiol Exp (Wars) 69: 189-197.
  • Gillberg C (2009) Autism and autistic-like conditions. In: Diseases of the Nervous System in Childhood (Aicardi J, ed.). MacKeith Press, London, United Kingdom, p. 902­921.
  • Gosselin NH, Brunet RC, Carrier G, Bouchard M, Feeley M (2006) Reconstruction of methylmercury intakes in indig­enous populations from biomarker data. J Expo Sci Environ Epidemiol 16: 19-29.
  • Hertz-Picciotto I, Delwiche L (2009) The rise in autism and the role of age at diagnosis. Epidemiol 20: 84-90.
  • Hewitson L, Houser LA, Stott C, Sackett G, Tomko JL, Atwood D, Blue L, White ER, Wakefield AJ (2009) Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. Neurotoxicol Oct 1, 2009. [Epub ahead of print. This article was withdrawn at the request of the publisher for political reasons according to the main author].
  • Holmes AS, Blaxill MF, Haley BE (2003) Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22: 277-285.
  • Hornig M, Chian D, Lipkin WI (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9: 833-845.
  • Hviid A, Stellfeld M, Wohlfahrt J, Melbye M (2003) Association between thimerosal -containing vaccine and autism. JAMA 290: 1763-1766.
  • Ip P, Wong V, Ho M, Lee J, Wong W (2004) Mercury expo­sure in children with autistic spectrum disorder: case -control study. J Child Neurol 19: 431-434.
  • Isaacs T (2010) Central figure In CDC vaccine safety studies investigated for fraud. [Avaiable at: http://www.natural- news.com/028558_vaccines_fraud.html].
  • James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S (2005) Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicol 26: 1-8.
  • James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141B: 947-956.
  • Kern JK, Jones AM (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9: 485-499.
  • Kern JK, Grannemann BD, Trivedi MH, Adams JB (2007) Sulfhydryl-reactive metals in autism. J Toxicol Environ Health A70: 715-721.
  • Kidd PM (2002) Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev 7: 472-499.
  • Lok E (1983) The effect of weaning on blood, hair, fecal and urinary mercury after chronic ingestion of methylmercu- ric chloride by infant monkeys. Toxicol Lett 15: 147­152.
  • Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB (2003) Thimerosal and the occurrence of autism: negative eco­logical evidence from Danish population-based data. Pediatrics 112: 604-606.
  • Magos L, Clarkson TW (2008) The assessment of the con­tribution of hair to methyl mercury excretion. Toxicol Lett 182: 48-49.
  • Merrick J, Kandel I, Morad M (2004) Trends in autism. Int J Adolesc Med Health 16: 75-78.
  • Mutter J, Naumann J, Schneider R, Walach H, Haley B (2005) Mercury and autism: accelerating evidence? Neuro Endocrinol Lett 26: 439-446.
  • Mutter J, Naumann J, Guethlin C (2007) Comments on the article "The toxicology of mercury and its chemical com­pounds" by Clarkson and Magos (2006) Crit Rev Toxicol 37: 537-552.
  • Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R (2006) Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 214: 99-108.
  • Newbury DF, Warburton PC, Wilson N, Bacchelli E, Carone S; International Molecular Genetic Study of Autism Consortium, Lamb JA, Maestrini E, Volpi EV, Mohammed S, Baird G, Monaco AP (2009) Mapping of partially overlapping de novo deletions across an autism susceptibility region (AUTS5) in two unrelated individuals affected by developmental delays with communication impairment. Am J Med Genet A 149A: 588-597.
  • Nielsen JB, Andersen O, Grandjean P (1994) Evaluation of mercury in hair, blood and muscle as biomarkers for methylmercury exposure in male and female mice. Arch Toxicol 68: 317-321.
  • Olczak M, Duszczyk M, Mierzejewski P, Majewska MD (2009) Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res 1301: 143-151.
  • Palmer RF, Blanchard S, Wood R (2009) Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15: 18-24.
  • Parran DK, Barker A, Ehrich M (2005) Effects of thimerosal on NGF signal transduction and cell death in neuroblas- toma cells. Toxicol Sci. 86: 132-140.
  • Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L,
  • Treanor J (2008) Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 121: 208-214.
  • Piotrowski JK, Trojanowska B, Sapota A (1974) Binding of cadmium and mercury by metallothionein in the kidneys and liver of rats following repeated administration. Arch Toxicol 32: 351-360.
  • Prandota J (2010) Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroin­flammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Res Autism Spectr Disord 4: 119-155.
  • Qvarnstrom J, Lambertsson L, Havarinasab S, Hultman P, Frech W (2003) Determination of methylmercury, ethyl- mercury, and inorganic mercury in mouse tissues, follow­ing administration of thimerosal, by species-specific iso­tope dilution GC-inductively coupled plasma-MS. Anal Chem 75: 4120-4124.
  • Refsvik T, Norseth T (1975) Methyl mercuric compounds in rat bile. Acta Pharmacol Toxicol (Copenh). 36: 67-78.
  • Robison LM, Sclar DA, Skaer TL, Galin RS (1999) National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990 -1995. Clin Pediatr (Phila) 38: 209-217.
  • Rowland IR, Robinson RD, Doherty RA (1984) Effects of diet on mercury metabolism and excretion in mice given methylmercury: role of gut flora. Arch Environ Health 39: 401-408.
  • Rowe KS, Rowe KJ (1997) Norms for parental ratings on Conners' Abbreviated Parent-Teacher Questionnaire: implications for the design of behavioral rating invento­ries and analyses of data derived from them. J Abnorm Child Psychol 25: 425-451.
  • Sandman CA (1988) Beta-endorphin disregulation in autis­tic and self-injurious behavior: a neurodevelopmental hypothesis. Synapse 2: 193-199.
  • Sandyk R, Gillman M (1986) Infantile autism: a dysfunction of the opioids? Med Hypotheses 19: 41-45.
  • Schopler E, Reichler RJ, DeVellis RF, Daly K (1980) Toward objective classification of childhood autism:
  • Childhood Autism Rating Scale (CARS). J Autism Dev Disord 10: 91-103.
  • Shayer M, Ginsburg D, Coe R (2007) Thirty years on - a large anti-Flynn effect? The Piagetian test Volume and Heaviness norms 1975 -2003. Br J Educ Psychol 77: 25-41.
  • Stajich GV, Lopez GP, Harry SW, Sexson WR (2000) Iatrogenic exposure to mercury after hepatitis B vaccina­tion in preterm infants. J Pediatr 136: 679-681.
  • Thomas DJ, Fisher HL, Sumler MR, Marcus AH, Mushak P, Hall LL (1986) Sexual differences in the distribution and retention of organic and inorganic mercury in methyl mercury-treated rats. Environ Res 41: 219­234.
  • Waalkes MP, Klaassen CD (1984) Postnatal ontogeny of metallothionein in various organs of the rat. Toxicol Appl Pharmacol 74: 314-320.
  • West AK, Hidalgo J, Eddins D, Levin ED, Aschner M (2008) Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicol 29: 489-503.
  • Windham GC, Zhang L, Gunier R, Croen LA, Grether JK (2006). Autism spectrum disorders in relation to distribu­tion of hazardous air pollutants in the San Francisco bay area. Environ Health Perspect 114: 1438-1444.
  • Wong V (2007) Erratum: J Child Neurol 22: 1324.
  • Woods JS, Echeverria D, Heyer NJ, Simmonds PL, Wilkerson J, Farin FM (2005) The association between genetic poly­morphisms of coproporphyrinogen oxidase and an atypi­cal porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 206: 113-120.
  • Yel L, Brown LE, Su K, Gollapudi S, Gupta S (2005) Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int J Mol Med 16: 971-977.
  • Young H, Geier D, Geier M (2008) Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink J Neurol Sci 271: 110-118.
  • Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, Meram I (2004) Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254: 143-147.

Uwagi

PL
Rekord w opracowaniu

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-8f3af980-dc2d-4b1f-b494-9399cde2afad
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.